A clinical trial of a new treatment, such as targeted therapy.

Moreover, the targeted therapies are not completely free of side effects.

And in some cases, the targeted therapy works best when used with conventional chemotherapy.

And experts predict that these targeted therapies are just the beginning.

Targeted therapy can stop cancer cells from growing or spreading.

It is also participating in clinical drug trials and research of targeted therapy.

Targeted therapies can stop this protein from promoting the growth of cancer cells.

Cancer vaccines and gene therapy may be considered targeted therapies.

Targeted therapy is currently being studied for treatment of pancreatic cancer.

At this time, targeted therapies are used for advanced stages of lung cancer.

Today, targeted therapy is all over the news - it is the new wave of cancer treatment.

Vaccine therapy can also be a type of targeted therapy.

Last month, Lilly's vision of targeted therapies gained some ground - albeit at another company.

Targeted therapies affect the specific mechanisms that allow cancer cells to grow.

The newer targeted therapies generally have fewer side effects than older chemotherapy drugs.

Targeted therapies are newer drugs that target specific properties within cancer cells.

This observation provides a novel approach to molecular targeted therapy, "wrapping technology".

In recent years, various molecular targeted therapies have been developed for the treatment of advanced lung cancer.

Instead there are targeted therapies which do not involve the removal of any organs or serious surgery.

In other studies presented here, two so-called targeted therapies developed by biotechnology companies were found to have extended the lives of people with cancer.

Targeted therapy may be considered the current pinnacle of advances spawned by such insights.

Such targeted therapy holds great promise in the treatment of diseases such as cancer.

At present, he and his colleagues are concentrating on the development of molecularly targeted therapies for individual patients with cancer.

There is virtually no data regarding new molecular targets or targeted therapy in the literature to date.

Such so-called targeted therapies generally have fewer side effects than conventional chemotherapy, some doctors say.